CRAIG W. CARLSON
CHIEF FINANCIAL OFFICER

Over the past 23 years of his career, Craig has held senior financial and operational positions in the biotech, biopharmaceutical, and medical device industries. He has significant experience raising capital from private and public markets, directing M&A activities, and has also had significant international experience having been responsible for various subsidiaries in China, Korea and the United Kingdom.

Previously, Craig was the Senior Vice President, Chief Financial Officer and Corporate Secretary at Talon Therapeutics, a specialty bio-pharmaceutical company that received FDA approval for its lead product to treat leukemia. He was responsible for all finance, accounting, SEC filings, investor relations, information technology, human resources, and intellectual property with financial oversight on clinical trials. During his time at Talon, he played an integral role in securing $100 million in financing; managed the Goldman Sachs M&A efforts; updated and streamlined Sarbanes Oxley controls and procedures; renegotiated licensing and royalty agreements, and actively participated in positioning the company for sale to Spectrum Pharmaceuticals in 2013.

He served a similar role as Senior Vice President, Chief Financial Officer, Chief Operating Officer and Managing Director UK for Cygnus Inc., a medical device company focused on manufacturing transdermal drug delivery systems and non-invasive glucose monitoring devices. At Cygnus, Craig supported the raise of more than $250 million from public and private markets alongside licensing fees. He led the licensing negotiations for U.S. sales and distribution agreements as well as the national launch of the world’s first non-invasive glucose monitoring device. He was deeply involved in the company’s sale of their transdermal patch business division to Johnson & Johnson.

Craig was the Chief Financial Officer at Neurobiological Technologies, a biotech company focused on Phase III trials for Ischemic Stroke, where he was instrumental in raising over $70 million in the midst of a difficult funding environment. He also served as the Chief Financial Officer and Chief Operating Officer of a privately held new business incubator responsible for, among other things, managing subsidiaries in China and Korea.

Craig has an MBA from Stanford University Graduate School of Business, an MS from Hofstra University and a BA in Political Science from Union College, Schenectady, NY.